Loading

Platform Licensing: Biotech and Pharma Perspectives

June 16, 2025
Breakout Session
Business Development and Investment
This past year has seen many early-stage deals involving platform technologies ranging from AI drug discovery to building blocks for gene therapy products. In this panel, speakers will explore platform technologies from a variety of different perspectives, including addressing the benefits of having a platform, what makes something a platform, different types of platforms, how platforms impact deal structures, and the complexities platforms introduce in negotiations. Additionally, panelists will discuss real-world examples to illustrate the practical applications and challenges of implementing these technologies across various sectors. Attendees will experience an insightful and engaging discussion on the future of platform technologies.
Moderator
Oren Livne, JD/MBA
Partner
Baker McKenzie
Speakers
Casarine Chong, JD, MBA
Senior Vice President, Deputy General Counsel, Transactions
Bristol Myers Squibb
Gavin Liu, JD
Senior Director, Legal Strategic Transactions
Astellas
Ellen Lubman, MBA
Advisor
Werewolf Therapeutics
Maria Nichol, CPA, EPA, DPhil
Chief Business Officer
Artax Biopharma
Deepa Talpade, PhD
Vice President, Head BD&L and Alliance Mgmt., Oncology
Bayer

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS